News

Stock Movers: Novo Nordisk, GoodRX, CVS

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Why Novo Nordisk Stock Popped Monday

Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...

Drugmaker halves price of Ozempic for Americans amid Trump crackdown

The maker of Ozempic is halving the price of its weight-loss jabs in the US after Donald Trump demanded cheaper drugs for ...

How Ozempic’s Maker Lost Its Shine After Creating a Wonder Drug

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...
The Pharma Letter2d

MASH win for Novo Nordisk’s Wegovy

Denmark’s Novo Nordisk scored a significant regulatory win for GLP-1drug Wegovy (semaglutide), as the US Food and Drug ...
Zacks.com on MSN3d

Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave?

Maziar Mike Doustdar takes office as NVO's new CEO, bringing a proven global growth record to tackle rising obesity market ...
Tampa Free Press on MSN3d

Vision Loss Lawsuits Mount Against Ozempic Manufacturer

Loss Drug to Irreversible Blindness A growing wave of lawsuits is targeting Novo Nordisk, the manufacturer of the widely used ...
BioSpace5d

A Compounding Problem: How GLP-1s Drove Novo Nordisk’s Rapid Rise and Fall

Novo Nordisk has plummeted back to Earth after a stunning rise driven by Ozempic and Wegovy. Can the storied Danish pharma ...